| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
(1R, 3R, 4R)-Entecavir
|
1367369-76-3 |
(1R, 3S, 4S)-恩替卡韦
|
(1R,3S,4S)-恩替卡韦;恩替卡韦杂质RRR;(1R,3R,4R)-ENTECAVIR,2-AMINO-1,9-DIHYDRO-9-[(1R,4R)-4-HYDROXY-3-(HYDROXYMETHYL)-2-METHYLENECYCLOPENTYL]-6H-PURIN-6-ONE;(1R,4R)-恩替卡韦;恩替卡韦(R,R,R)-异构体;1,4EPI恩替卡韦 (1R,4R)
|
C12H15N5O3 |
277.2792 | |
|
4-Dimethylsilyl Entecavir
|
870614-82-7 |
恩替卡韦杂质
|
4-二甲基硅基恩替卡韦;恩替卡韦杂质22;4-DIMETHYLSILYL恩替卡韦
|
C14H21N5O3Si |
335.43374 | |
|
Entacapone Impurity 11
|
857629-78-8 |
恩他卡朋杂质G
|
恩他卡朋杂质G;安托卡朋杂质G;(E)-3-O-甲基恩他卡朋
|
C12H17NOS |
223.33448 | 617-756-8 |
|
Enalapril EP Impurity D
|
115729-52-7 |
依那普利二酮哌嗪
|
依那普利二酮哌嗪;依那普利EP杂质D;杂质Ⅱ(依那普利双酮);依那普利二氧代哌嗪;依那普利二酮哌嗪 标准品
|
C20H26N2O4 |
358.43144 | |
|
2-epi-Emtricitabine
|
145416-34-8 |
2-表艾美他滨
|
恩曲他滨–对映体杂质;2-表艾美他滨
|
C8H10FN3O3S |
247.246703 | |
|
Emtricitabine S-Oxide
|
152128-77-3 |
恩曲他滨S-氧化物(非对映体混合物)
|
恩曲他滨杂质 II(恩曲他滨氧化杂质);恩曲他滨S-氧化物(非对映体混合物);恩曲他滨 S-氧化物;(2R,3R,5S)-5-氟-1-[2-羟甲基-3-氧-1,3-氧硫环-5-基]胞嘧啶;恩曲他滨杂质II;恩曲他滨亚砜;EMTRICITABINE S-OXIDE (EMTRICITABINE SULFOXIDE)
|
C8H10FN3O4S |
263.2461032 | |
|
Efavirenz Related Compound B
|
440124-96-9 |
(S,E)-6-氯-4-(2-环丙乙烯)-4-(三氟甲基)-2H-3,1-苯并噁唑-2-酮
|
(S,E)-6-氯-4-(2-环丙乙烯)-4-(三氟甲基)-2H-3,1-苯并噁唑-2-酮;依非韦伦相关物质B;依非韦伦杂质2;依法韦仑相关物质B;(4S)-6-氯-4-[(1E)-2-环丙基乙烯基]-1,4-二氢-4-(三氟甲基)-2H-3,1-苯并恶嗪-2-酮;依非韦伦相关杂质B
|
C14H11CLF3NO2 |
317.69 | |
|
5-Methyl-4,5,6,7-Tetrahydrothiazolo[5,4-c]Pyridine-2-Carboxylic Acid Hcl
|
720720-96-7 |
4,5,6,7-四氢-5-甲基-噻唑并[5,4-C]吡啶-2-羧酸·盐酸盐
|
4-C]吡啶-2-羧酸 盐酸盐;7-四氢-5-甲基-噻唑并[5;4,5,6,7-四氢-5-甲基-噻吩并[5,4-C]吡啶-2-羧酸·盐酸盐;5-甲基-4,7-四氢噻唑并[5,4-C]吡啶-2-甲酸盐酸盐;EDOXABAN-2;4,7-四氰-5-甲基-噻唑并(5,4-C)吡啶-2-羧酸盐酸盐;5-甲基-4,7-四氢噻唑[5,4-C]吡啶-2-甲酸盐酸盐;4,7-四氢-5-甲基-噻唑并[5,4-C]吡啶-2-羧酸·盐酸盐 (依度沙班中间体)100G
|
C8H10N2O2S.HCl |
234.70314 | 1592732-453-0 |
|
EthanediaMide iMpurity A
|
1210348-34-7 |
伊多塞班中间体2
|
4S)-1-氨基-4-(二甲基氨基羰基)-环己基-2-氨基甲酸叔丁酯草酸盐;(1S,2R,4S)-1-氨基-4-(二甲基氨基羰基)-环己基-2-氨基甲酸叔丁酯草酸盐,伊多塞班中间体,依度沙班中间体;EDOXABAN-1;依度沙班中间体5;[(1R,2S,5S)-2-氨基-5-[(二甲基氨基)羰基]环己基]氨基甲酸叔丁酯草酸盐;依度沙班;伊多塞班中间体2;(1R,5S)-1-氨基-4-(二甲基氨基羰基)-环己基-2-氨基甲酸叔丁酯草酸盐,依度沙班中间体
|
C16H27N5O7 |
401.41488 | 1592732-453-0 |
|
Edaravone Impurity V
|
124009-63-8 |
依达拉奉三聚体杂质
|
依达拉奉三聚体杂质;依达拉奉三聚体;EDARAVONE-2;依达拉奉杂质2对照品;5,5''-二羟基-3,3',3''-三甲基-1,1',1''-三苯基-[4,4':4',4''-三联-1H-吡唑]-5'(4'H)-酮;依达拉奉杂质F
|
C30H26N6O3 |
518.56584 | |
|
Edaravone Impurity III
|
1357477-99-6 |
依达拉奉P1杂质
|
依达拉奉P1杂质;依达拉奉P1;EDARAVONE-3;依达拉奉杂质P1对照品;4,5-二氢-ALPHA,3-二甲基-5-氧代-1-苯基-ALPHA-磺基-1H-吡唑-4-乙酸;依达拉奉杂质P1
|
C13H14N2O6S |
326.32506 | |
|
Edaravone Impurity 25
|
29214-62-8 |
依达拉奉杂质
|
依达拉奉标准品007;依达拉奉杂质25
|
C8H12O4 |
172.17848 | 249-519-6 |
|
5beta-Dutasteride
|
957229-52-6 |
5beta-度他雄胺
|
5Β-度他雄胺;5Β-羟基度他雄胺;度他雄胺5-BETA异构体;5-BETA-度他雄胺
|
C27H30F6N2O2 |
528.5297192 | |
|
Duloxetine Impurity 14
|
878757-08-5 |
度洛西汀杂质09
|
度洛西汀杂质09;度洛西汀杂质9;DULOXETINE-10
|
C19H21NOS |
311.44114 | |
|
Doxylamine EP Impurity A
|
873407-01-3 |
盐酸多西拉敏杂质A
|
盐酸多西拉敏杂质A;多西拉敏杂质A HCL
|
C17H22N2O |
270.36938 | |
|
Doxycycline Hyclate Impurity F
|
122861-53-4 |
盐酸强力霉素杂质F
|
强力霉素杂质2;盐酸强力霉素杂质F;盐酸多西环素杂质F
|
C23H25NO8 |
443.4465 | |
|
Doxorubicin Impurity 2
|
64845-67-6 |
阿霉素杂质2
|
阿霉素杂质2;多柔比星杂质2
|
C19H12O6 |
336.29498 | |
|
8-Desacetyl-8-carboxy daunorubicin hydrochloride
|
58199-96-5 |
盐酸氟西汀杂质
|
道诺霉素盐酸盐杂质
|
C26H27NO11.CLH |
565.956 | |
|
Theophylline Impurity 2
|
5614-53-9 |
茶碱杂质2
|
DOXOFYLLINE-1;多索茶碱杂质01;茶碱杂质2
|
C9H10N4O3 |
222.2007 | |
|
2,2'-(1,4-Piperazinediyl)bis[6,7-dimethoxy-4-quinazolinamine]
|
102839-00-9 |
特拉唑嗪杂质E
|
哌唑嗪EP杂质E;特拉唑嗪EP杂质E;特拉唑嗪杂质9;多沙唑嗪EP杂质H;2,2'-(1,4-哌嗪二基)二[6,7-二甲氧基-4-喹唑啉胺];特拉唑嗪标准品006
|
C24H28N8O4 |
492.53032 |
药智官方微信
药智官方微博
